TriSalus Life Sciences In...

5.50
-0.02 (-0.36%)
At close: Apr 01, 2025, 3:59 PM
5.54
0.76%
After-hours: Apr 01, 2025, 04:01 PM EDT

TriSalus Life Sciences Ratios Statement

Year FY23 FY22 FY21 FY20
PE Ratio -1.34 -6.29 -10.7 -10.1
PEG Ratio -0.00 -0.09 0.93 n/a
PS Ratio 4.29 23.95 36.75 59.16
PB Ratio -3.06 -1.68 -2.38 1.41
P/FCF Ratio -1.55 -8.97 -12.89 -262.96
P/OCF Ratio -1.59 -9.19 -13.6 -474.47
OCF/S Ratio -2.7 -2.61 -2.7 -0.12
Debt / Equity Ratio -0.06 -0.01 -0.00 0.18
Quick Ratio 1.25 0.49 5.31 13.96
Current Ratio 1.42 0.53 5.51 19.46
Asset Turnover 0.72 0.56 0.22 0.02
Interest Coverage -3.38K -36.44K -13.65 n/a
Return on Equity (ROE) n/a n/a n/a n/a
Return on Assets (ROA) n/a n/a n/a n/a
Return on Capital (ROIC) n/a n/a n/a n/a
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin 85.93% 81.79% 85.80% 59.55%
Net Profit Margin -318.93% -380.6% -343.35% -585.76%
Pretax Profit Margin -318.89% -380.53% -343.32% -585.68%
Operating Profit Margin -292.53% -293.91% -286.06% -471.95%
FCF Margin -276.41% -266.97% -285.14% -22.5%
EBITDA Margin -314.94% -377.18% -280.54% -466.05%